Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-15 Sale | 2025-05-19 5:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 52 | $424.69 | $22,084 | 23,281 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 5:00 pm | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 1,001 | $0 | $0 | 4,830 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:52 pm | VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director | 1,001 | $0 | $0 | 9,429 (Indirect Direct) | View |
| 2025-05-02 Sale | 2025-05-05 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 400 | $505.86 | $202,344 | 4,831 (Direct) | View |
| 2025-03-13 Sale | 2025-03-17 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $510 | $1,647,810 | 23,281 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,298 | $500 | $1,649,000 | 51,671 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,242 | $499.99 | $1,620,968 | 51,239 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $500 | $1,615,500 | 26,512 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,058 | $485.49 | $1,970,118 | 54,481 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $490 | $1,583,190 | 29,743 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 530 | $475.34 | $251,930 | 58,539 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,650 | $475.34 | $1,259,651 | 19,352 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 1,272 | $480 | $610,560 | 32,974 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:15 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 354 | $480.95 | $170,256 | 64,031 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,767 | $480.95 | $849,839 | 24,484 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 884 | $480.95 | $425,160 | 9,086 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:04 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 848 | $480.95 | $407,846 | 40,200 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 1,111 | $480 | $533,280 | 45,019 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-07-02 4:20 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 0 | $0 | 16,130 (Direct) | View |
| 2025-07-01 Tax Withholding | 2025-07-02 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 37,243 | $450.23 | 63,508 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-15 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 37,622 | $0 | 100,751 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 5:00 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 1,797 | $0 | 4,830 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:59 pm | N/A 2035-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Thornberry Nancy Director | 1,597 | $0 | 3,234 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:57 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Schneider Jennifer Director | 796 | $0 | 1,718 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:55 pm | N/A 2035-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 2,398 | $0 | 2,398 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:52 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director | 1,797 | $0 | 9,429 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:20 pm | N/A 2035-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Lagarde Michel Director | 2,398 | $0 | 2,398 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:19 pm | N/A 2035-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director | 1,597 | $0 | 8,071 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director | 796 | $0 | 7,115 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 796 | $0 | 4,831 (Direct) | View |
| 2025-04-15 Option Award | 2025-04-17 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 72 | $497.51 | 1,475 (Direct) | View |
| 2025-04-15 Option Award | 2025-04-17 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 95 | $497.51 | 15,240 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:52 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 4,962 | $479.61 | 54,969 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,962 | $479.61 | 58,539 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:46 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 3,703 | $479.61 | 69,372 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 14,079 | $479.61 | 105,915 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:41 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 4,962 | $479.61 | 32,669 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,482 | $479.61 | 19,352 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:31 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 7,071 | $479.61 | 63,075 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,241 | $479.61 | 7,845 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 5,954 | $479.61 | 32,974 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,310 | $483.28 | 59,931 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:15 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,310 | $483.28 | 64,031 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,470 | $483.28 | 73,075 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,386 | $483.28 | 119,994 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 3,310 | $483.28 | 37,631 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,656 | $483.28 | 24,484 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,716 | $483.28 | 70,146 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 828 | $483.28 | 9,086 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:04 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,971 | $483.28 | 40,200 (Direct) | View |